A phase 1b/2 study of omaveloxolone in combination with checkpoint inhibitors in patients with unresectable or metastatic melanoma
Publication
, Conference
Patel, SP; Hodi, FS; Gabrilovich, D; Chin, M; Gibney, G; Goldsberry, A; Gonzalez, R; Hurt, J; Markowitz, J; Whitman, E; Meyer, C; Salama, A
Published in: Annals of Oncology
December 1, 2017
Duke Scholars
Published In
Annals of Oncology
DOI
EISSN
1569-8041
ISSN
0923-7534
Publication Date
December 1, 2017
Volume
28
Start / End Page
xi30
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Patel, S. P., Hodi, F. S., Gabrilovich, D., Chin, M., Gibney, G., Goldsberry, A., … Salama, A. (2017). A phase 1b/2 study of omaveloxolone in combination with checkpoint inhibitors in patients with unresectable or metastatic melanoma. In Annals of Oncology (Vol. 28, p. xi30). https://doi.org/10.1093/annonc/mdx760
Patel, S. P., F. S. Hodi, D. Gabrilovich, M. Chin, G. Gibney, A. Goldsberry, R. Gonzalez, et al. “A phase 1b/2 study of omaveloxolone in combination with checkpoint inhibitors in patients with unresectable or metastatic melanoma.” In Annals of Oncology, 28:xi30, 2017. https://doi.org/10.1093/annonc/mdx760.
Patel SP, Hodi FS, Gabrilovich D, Chin M, Gibney G, Goldsberry A, et al. A phase 1b/2 study of omaveloxolone in combination with checkpoint inhibitors in patients with unresectable or metastatic melanoma. In: Annals of Oncology. 2017. p. xi30.
Patel, S. P., et al. “A phase 1b/2 study of omaveloxolone in combination with checkpoint inhibitors in patients with unresectable or metastatic melanoma.” Annals of Oncology, vol. 28, 2017, p. xi30. Scopus, doi:10.1093/annonc/mdx760.
Patel SP, Hodi FS, Gabrilovich D, Chin M, Gibney G, Goldsberry A, Gonzalez R, Hurt J, Markowitz J, Whitman E, Meyer C, Salama A. A phase 1b/2 study of omaveloxolone in combination with checkpoint inhibitors in patients with unresectable or metastatic melanoma. Annals of Oncology. 2017. p. xi30.
Published In
Annals of Oncology
DOI
EISSN
1569-8041
ISSN
0923-7534
Publication Date
December 1, 2017
Volume
28
Start / End Page
xi30
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis